439 377

Cited 54 times in

Dyslipidemia Fact Sheets in Korea 2020: an Analysis of Nationwide Population-based Data

DC Field Value Language
dc.contributor.author김현창-
dc.contributor.author이혁희-
dc.contributor.author이호규-
dc.date.accessioned2021-09-29T01:13:27Z-
dc.date.available2021-09-29T01:13:27Z-
dc.date.issued2021-05-
dc.identifier.issn2287-2892-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/184254-
dc.description.abstractObjective: The Korean Society of Lipid and Atherosclerosis (KSoLA) has published the Dyslipidemia Fact Sheets in Korea 2020 to provide an overview of magnitude and management status of dyslipidemia and their recent trends therein. Methods: The Fact Sheets were based on the analyses of Korean adults aged 20 years or older of the 2007-2018 Korea National Health and Nutrition Examination Survey (KNHANES) and the 2002-2018 National Health Insurance Big Data (NHI-BD). Results: Between 2007 and 2018, the crude prevalence of hypercholesterolemia increased from 9.0% to 20.7%. During the same period, its management rate also improved yet remained unsatisfactory. In 2018, the prevalence of dyslipidemia was 45.6% in men and 31.3% in women, which increased with older age and presence of metabolic abnormalities. Indeed, the number of people diagnosed with dyslipidemia has increased nearly 8-fold from 1.5 million in 2002 to 11.6 million in 2018; alongside, the number of people receiving pharmacological treatment for dyslipidemia has also risen. Of the 7.7 million people treated for dyslipidemia in 2018, statin accounted for the majority (91.8%) of lipid-lowering drug prescriptions, followed by ezetimibe (14.6%), fibrate (8.5%), and omega-3 acid (5.9%). The most frequently used combination therapy was statin plus ezetimibe, accounting for 72% of dual therapy prescriptions. Conclusion: Dyslipidemia continues to impose a substantial disease burden in Korea. Both healthcare practitioners and patients need to actively adopt guideline-recommended lifestyle modification and pharmacological treatment for comprehensive, timely, and sustained management.-
dc.description.statementOfResponsibilityopen-
dc.languageKorean-
dc.publisher한국지질동맥경화학회-
dc.relation.isPartOfJournal of Lipid and Atherosclerosis-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleDyslipidemia Fact Sheets in Korea 2020: an Analysis of Nationwide Population-based Data-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Preventive Medicine (예방의학교실)-
dc.contributor.googleauthorSo Mi Jemma Cho-
dc.contributor.googleauthorHokyou Lee-
dc.contributor.googleauthorHyeok-Hee Lee-
dc.contributor.googleauthorJongmin Baek-
dc.contributor.googleauthorJi Eun Heo-
dc.contributor.googleauthorHyung Joon Joo-
dc.contributor.googleauthorSoon Jun Hong-
dc.contributor.googleauthorHyeon Chang Kim-
dc.identifier.doi10.12997/jla.2021.10.2.202-
dc.contributor.localIdA01142-
dc.contributor.localIdA06102-
dc.contributor.localIdA05838-
dc.relation.journalcodeJ01562-
dc.identifier.eissn2288-2561-
dc.identifier.pmid34095012-
dc.subject.keywordDyslipidemias-
dc.subject.keywordHypercholesterolemia-
dc.subject.keywordKorea-
dc.subject.keywordLipids-
dc.contributor.alternativeNameKim, Hyeon Chang-
dc.contributor.affiliatedAuthor김현창-
dc.contributor.affiliatedAuthor이혁희-
dc.contributor.affiliatedAuthor이호규-
dc.citation.volume10-
dc.citation.number2-
dc.citation.startPage202-
dc.citation.endPage209-
dc.identifier.bibliographicCitationJournal of Lipid and Atherosclerosis, Vol.10(2) : 202-209, 2021-05-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.